Overview

Efficacy and Safety of Cinacalcet in Pediatric Patients With Secondary Hyperparathyroidism (SHPT) and Chronic Kidney Disease (CKD) on Dialysis

Status:
Terminated
Trial end date:
2016-06-23
Target enrollment:
Participant gender:
Summary
The primary objective was to evaluate the efficacy of cinacalcet for reducing the plasma intact parathyroid hormone (iPTH) level by ≥ 30%.
Phase:
Phase 3
Details
Lead Sponsor:
Amgen
Treatments:
Calcium, Dietary
Cinacalcet
Cinacalcet Hydrochloride
Ergocalciferols
Vitamin D
Vitamins